Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dabigatran in Acute Intermediate-Risk Pulmonary Embolism
NCT02596555Phase 4Terminated
- Start
- Jan 2016
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
A Phase 4 trial of dabigatran in pulmonary embolism (PE). Started Jan 2016; status: terminated.
02
Drugs
dabigatran
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02596555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02596555.